A blood clotting monitor for children having heart surgery
Part of Blood & lymphatic, Injuries & trauma clinical trials.
This study tests a device that checks how well blood clots during and after heart or blood vessel surgery in children. The goal is to help doctors quickly manage bleeding or clotting risks in young patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be under 18 years old.
- Must be having heart or blood vessel surgery, OR have recently had such surgery and now have bleeding or blood clotting problems.
- If the patient is a baby, they must have been born at or after 37 weeks of pregnancy.
- Cannot be enrolled in another study that might interfere with this one.
- Must have a parent or guardian sign a consent form (and the child must agree if appropriate).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new device, called Quantra, that checks how well your child's blood clots during surgery. By comparing its results to standard lab tests in healthy children, researchers hope to confirm it is accurate and useful for guiding treatment in kids.
This trial checks whether a bedside machine (TEG 6s) can measure blood clotting in children during planned surgery. It may help doctors get faster, more accurate information about clotting during the operation.
This study tests a special tool called Quantra, which helps doctors decide when to give blood products during your liver transplant. The goal is to make sure you get just the right amount of transfusions, which could improve your safety and recovery.
This study uses a special device (Sonoclot) to closely monitor how a trauma patient's blood clots. The goal is to help doctors better manage bleeding after injury.
This study tests an investigational medical device (the UltraTrac) worn on the skin while children undergo a routine heart catheterization. The device aims to improve monitoring during the procedure and may help guide care more safely.
This study tests a quick bedside measurement of how well the drug tranexamic acid works to prevent bleeding during heart surgery. It may help doctors give the right dose to reduce blood loss.
Hear when a new Blood Loss, Surgical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.